Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miles D Witham

Showing results (231-240 of 240) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 240 results.
Journal of the American Heart Association|June 1, 2018
Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-AnalysisLouise A Beveridge, Faisel Khan, Allan D Struthers, et al.
Nutrients|August 10, 2021
Nutrition and Frailty: Opportunities for Prevention and TreatmentMary Ni Lochlainn, Natalie J Cox, Thomas Wilson, et al.
Journal of Multimorbidity and Comorbidity|February 3, 2025
Building ADMISSION - A research collaborative to transform understanding of multiple long-term conditions for people admitted to hospitalMiles D Witham, Victoria Bartle, Sue Bellass, et al.
Plos One|November 14, 2023
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trialTufail Bashir, Marcus Achison, Simon Adamson, et al.
Plos One|October 20, 2023
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trialChristos Rossios, Tufail Bashir, Marcus Achison, et al.
Plos One|August 2, 2024
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trialAlvin Shrestha, Tufail Bashir, Marcus Achison, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 17, 2022
Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial, Marcus Achison, Simon Adamson, et al.
Eclinicalmedicine|March 20, 2023
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort studyHamish J C McAuley, Rachael A Evans, Charlotte E Bolton, et al.
Gerontology|July 2, 2020
The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and RationaleLena Tschiderer, Lisa Seekircher, Gerhard Klingenschmid, et al.
Circulation|June 18, 2020
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 PatientsPeter Willeit, Lena Tschiderer, Elias Allara, et al.
Pageof 24

Showing results (231-240 of 240) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 240 results.
Journal of the American Heart Association|June 1, 2018
Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-AnalysisLouise A Beveridge, Faisel Khan, Allan D Struthers, et al.
Nutrients|August 10, 2021
Nutrition and Frailty: Opportunities for Prevention and TreatmentMary Ni Lochlainn, Natalie J Cox, Thomas Wilson, et al.
Journal of Multimorbidity and Comorbidity|February 3, 2025
Building ADMISSION - A research collaborative to transform understanding of multiple long-term conditions for people admitted to hospitalMiles D Witham, Victoria Bartle, Sue Bellass, et al.
Plos One|November 14, 2023
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trialTufail Bashir, Marcus Achison, Simon Adamson, et al.
Plos One|October 20, 2023
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trialChristos Rossios, Tufail Bashir, Marcus Achison, et al.
Plos One|August 2, 2024
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trialAlvin Shrestha, Tufail Bashir, Marcus Achison, et al.
Journal of Cachexia, Sarcopenia and Muscle|February 17, 2022
Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial, Marcus Achison, Simon Adamson, et al.
Eclinicalmedicine|March 20, 2023
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort studyHamish J C McAuley, Rachael A Evans, Charlotte E Bolton, et al.
Gerontology|July 2, 2020
The Prospective Studies of Atherosclerosis (Proof-ATHERO) Consortium: Design and RationaleLena Tschiderer, Lisa Seekircher, Gerhard Klingenschmid, et al.
Circulation|June 18, 2020
Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 PatientsPeter Willeit, Lena Tschiderer, Elias Allara, et al.
Pageof 24